LUCRIN Safety Questions, LUCRIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about LUCRIN. Our extensive database of LUCRIN adverse events and LUCRIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about LUCRIN
LUCRIN Safety Reports
Total LUCRIN reports: 7.LUCRIN FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 3.
Take LUCRIN Side Effects Survey or Share Your LUCRIN Story. Read More Here.
Consumer or non-health professional from BELGIUM reported LUCRIN problem on Mar 06, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block complete, blood lactate dehydrogenase increased, cardiac arrest, cardiogenic shock, cough, dyskinesia. LUCRIN dosage: 11.25 MG (11.25 MG, 1 IN 3M) INJECTION. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM, ERGOCALCIFEROL, BICALUTAMIDE. Patient was hospitalized. Patient died.
LUCRIN problem was reported by a Consumer or non-health professional from BELGIUM on May 21, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: azotaemia, hydronephrosis, malignant neoplasm progression, metastases to bone, metastases to liver, metastases to lymph nodes, prostate cancer. LUCRIN dosage: 3.75 MG (3.75 MG, 1 IN 1 M);. During the same period patient was treated with CYPROTERONE ACETATE, DOCETAXEL. Patient was hospitalized. Patient died.
Physician from AUSTRALIA reported LUCRIN problem on Sept 11, 2006. Male patient, 64 years of age, was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: bone disorder, dysaesthesia, hypoaesthesia oral, impaired healing, oedema mucosal, osteonecrosis, pain in jaw, soft tissue infection. LUCRIN dosage: unknown. During the same period patient was treated with COSUDEX, ZOMETA. Patient recovered.
LUCRIN problem was reported by a Physician from BELGIUM on Sept 21, 2006. Male patient, 72 years of age, was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: open wound, osteonecrosis, pain in jaw. LUCRIN dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE, TAXOTERE, ZOMETA, HORMONES. Patient recovered.
Consumer or non-health professional from BELGIUM reported LUCRIN problem on Dec 12, 2006. Male patient, 71 years of age, was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: asthenia, decreased appetite, inadequate analgesia, nausea, prostatic specific antigen increased, vomiting. LUCRIN dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIIUM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, NIMESULIDE, ASPIRIN, BISOPROLOL FUMARATE, OMEPRAZOLE. Patient was hospitalized. Patient died.
LUCRIN problem was reported by a Consumer or non-health professional from AUSTRALIA on July 30, 2007. Male patient, 84 years of age, was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: muscle haemorrhage, muscle mass, muscle necrosis. LUCRIN dosage: 22.5 MG (22.5 MG, 1 IN 3 M) INTRAMUSCULAR. During the same period patient was treated with ASPIRIN, NICORANDIL, DIGOXIN, SOTALOL HYDROCHLORIDE, SIMVASTATIN. Patient recovered.
Consumer or non-health professional from BELGIUM reported LUCRIN problem on Aug 23, 2007. Male patient was diagnosed with prostate cancer and was treated with LUCRIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to bone, prostate cancer. LUCRIN dosage: 11.25 MG (11.25 MG, 1 IN 3 M) ONGOING UNTIL DEATH. During the same period patient was treated with CYPROTERONE ACETATE, BICALUTAMIDE. Patient died.